Compare RDNT & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDNT | ACMR |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | United States | United States |
| Employees | N/A | 2513 |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 1996 | 2017 |
| Metric | RDNT | ACMR |
|---|---|---|
| Price | $58.89 | $52.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $82.80 | $50.00 |
| AVG Volume (30 Days) | 709.7K | ★ 982.1K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.37 |
| Revenue | ★ $1,616,630,000.00 | $74,643,000.00 |
| Revenue This Year | $22.78 | $29.37 |
| Revenue Next Year | $10.70 | $23.16 |
| P/E Ratio | ★ N/A | $40.95 |
| Revenue Growth | 13.05 | ★ 104.47 |
| 52 Week Low | $50.15 | $17.32 |
| 52 Week High | $85.84 | $71.65 |
| Indicator | RDNT | ACMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 58.16 |
| Support Level | $51.59 | $49.37 |
| Resistance Level | $60.00 | $54.83 |
| Average True Range (ATR) | 2.78 | 2.66 |
| MACD | 0.46 | 1.11 |
| Stochastic Oscillator | 43.29 | 66.56 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.